Back to today’s briefing

Story perspectives

FDA Approves Vizz: New Eye Drops for Presbyopia

10/24/2025

27 4

Summary

Story summary

The U.S. Food and Drug Administration (FDA) approved Vizz, a prescription eye drop for presbyopia.
Vizz contains aceclidine and improves near vision within 30 minutes, lasting up to 10 hours, longer than Vuity and Qlosi.
About 128 million U.S. adults have presbyopia.
Samples may begin this month with broader availability planned by year-end.
The price is about $80 per month with insurance, and side effects include eye irritation and dim vision.

1 of 1

Story summary

The U.S. Food and Drug Administration (FDA) approved Vizz, a prescription eye drop for presbyopia.
Vizz contains aceclidine and improves near vision within 30 minutes, lasting up to 10 hours, longer than Vuity and Qlosi.
About 128 million U.S. adults have presbyopia.
Samples may begin this month with broader availability planned by year-end.
The price is about $80 per month with insurance, and side effects include eye irritation and dim vision.